# OnCo record isarna-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/isarna-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "isarna-therapeutics" ;
  schema:name "Isarna Therapeutics"@en ;
  schema:alternateName "Isarna Therapeutics GmbH"@en, "Antisense Pharma"@en ;
  schema:description "Isarna, formerly Antisense Pharma, is a Munich company whose TGF-beta2 antisense drug trabedersen was tested directly into brain tumours in phase 3 for high-grade glioma before the programme moved to eye disease."@en ;
  schema:url <https://onco.cc/companies/isarna-therapeutics/>, <http://www.isarna-therapeutics.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <http://www.isarna-therapeutics.com>, <https://clinicaltrials.gov/search?lead=Isarna%20Therapeutics%20GmbH>, <https://www.wikidata.org/wiki/Q50038820> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "DE" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/antisense-sirna/> ;
  onco:targets <https://onco.cc/pathways/tgf-beta/> ;
  onco:drugs <https://onco.cc/drugs/trabedersen/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .